Other than Dave helped facilitate a meeting for Brett with Arbiter in the next day or two, there's no new information in this material from where I sit.
Swing batter batter, swing.
If Brett would like to be truly helpful, he should offer to help assist the Company/Wanda/Dave compile and publish the various important details, default triggers, modification/extension provisions, etc for each and every convertible note currently outstanding for SIRC, including any and all warrants which may be remaining (to confirm what Dave said on a recent call). Would also like to see a detailed schedule of *HOW* each convertible note which came due during January, February and March 2022 has been resolved/reworked/repaid/remedied including any considerations or compensation which would have been provided. Now this would be helpful data to assess risk and potential mitigants. Hopefully the upcoming audited financial statements will capture this in significant detail in the "Subsequent Events" notes, but I remain cautious.
Until all of the toxic instruments get wiped clean, I struggle to see how SIRC successfully gets to NASDAQ (regardless of stock price). At this rate, it could be a year or more out in my opinion, regardless of their revenue/income run rate. That may severely disappoint some folks who believe differently.
News 
Market Data 
Discover 
